3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
25
Neoplasms
3
Neoplasm Metastasis
3
Stomach Neoplasms
1
Sarcoma
1
Osteitis Deformans
1
Neoplastic Cells, Circulating
1
Invasive Breast Cancer
1
Head and Neck Neoplasms
1
HER2-positive Advanced Breast Cancer
1
HER2+ Metastatic Breast Cancer (MBC)
1
HER2 Positive Metastatic Breast Cancer
1
Esophageal Neoplasms
1
Carcinoma
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Interventions
Folfox protocol
2
Standard of Care
1
Lapatinib
1
Drug Therapy
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplastic Cells, Circulating
×
Lapatinib
×
Clear all
NCT01619111
2024-06-04
DETECT III
University of Ulm
Phase 3
Completed
105 enrolled